IC
VRTX icon

IEQ Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

IEQ Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
27,175
+4,651
+21% +$2.17M 0.06% 305
2025
Q4 		$10.2M Buy
22,524
+16,073
+249% +$6.93M 0.03% 339
2025
Q3 		$2.53M Sell
6,451
-9,768
-60% -$4.08M 0.01% 679
2025
Q2 		$7.22M Sell
16,219
-5,786
-26% -$2.67M 0.04% 322
2025
Q1 		$10.7M Buy
22,005
+3,782
+21% +$1.76M 0.08% 182
2024
Q4 		$7.34M Sell
18,223
-4,358
-19% -$2.02M 0.07% 188
2024
Q3 		$10.5M Buy
22,581
+1,488
+7% +$715K 0.13% 116
2024
Q2 		$9.89M Buy
21,093
+1,877
+10% +$815K 0.13% 102
2024
Q1 		$8.03M Buy
19,216
+1,233
+7% +$521K 0.12% 118
2023
Q4 		$7.32M Buy
17,983
+500
+3% +$185K 0.12% 117
2023
Q3 		$6.08M Buy
17,483
+999
+6% +$349K 0.12% 114
2023
Q2 		$5.8M Buy
16,484
+1,638
+11% +$552K 0.12% 121
2023
Q1 		$4.68M Buy
14,846
+487
+3% +$146K 0.11% 137
2022
Q4 		$4.15M Buy
14,359
+840
+6% +$256K 0.12% 141
2022
Q3 		$3.91M Buy
13,519
+4,875
+56% +$1.4M 0.11% 141
2022
Q2 		$2.44M Buy
8,644
+1,601
+23% +$429K 0.07% 177
2022
Q1 		$1.84M Buy
7,043
+1,199
+21% +$285K 0.04% 224
2021
Q4 		$1.28M Buy
5,844
+2,209
+61% +$430K 0.03% 262
2021
Q3 		$659K Buy
3,635
+1,228
+51% +$240K 0.02% 365
2021
Q2 		$485K Sell
2,407
-102
-4% -$21.3K 0.01% 371
2021
Q1 		$539K Buy
+2,509
New +$551K 0.02% 271
2020
Q4 		– Sell
-2,078
Closed -$565K – 392
2020
Q3 		$565K Sell
2,078
-113
-5% -$31.2K 0.03% 223
2020
Q2 		$636K Sell
2,191
-13
-0.6% -$3.52K 0.04% 182
2020
Q1 		$524K Buy
2,204
+688
+45% +$158K 0.04% 197
2019
Q4 		$332K Buy
+1,516
New +$307K 0.03% 293

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

IEQ Capital's VRTX Position: Q1 2026 in Review

IEQ Capital increased its Vertex Pharmaceuticals (VRTX) stake by 21% in Q1 2026, buying an estimated $2.17M and bringing the position to 27,175 shares worth $12.1M. The position accounts for 0.06% of the portfolio, ranked #305.

IEQ Capital first reported a position in VRTX in Q4 2019 and has held it in 25 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • IEQ Capital held 27,175 shares of Vertex Pharmaceuticals worth $12.1M as of Q1 2026.
  • IEQ Capital bought 4,651 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.17M.
  • Vertex Pharmaceuticals made up 0.06% of IEQ Capital's portfolio in Q1 2026, its #305 holding.
  • IEQ Capital first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.